Market Tracker

06/30 6:16am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.4613
Delayed Data
As of Jun 29
 -0.0037 / -0.80%
Today’s Change
0.39
Today|||52-Week Range
6.44
-84.36%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close0.47
Today’s open0.47
Day’s range0.45 - 0.47
Volume3,513,315
Average volume (3 months)4,211,870
Market cap$28.4M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+41.01%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
PULMPulmatrix Inc-0.02-0.93%
HEBHemispherx Biopharma...+0.00+2.38%
OPXAOpexa Therapeutics I...+0.07+1.79%
OGXIOncoGenex Pharmaceut...+0.04+4.31%
Data as of 06/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts